- Home
- COOK vs FENC Comparison
COOK vs FENC Comparison
Compare COOK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- FENC
- Stock Information
- Founded
- COOK 1985
- FENC 1996
- Country
- COOK United States
- FENC United States
- Employees
- COOK N/A
- FENC 32
- Industry
- COOK Wholesale Distributors
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COOK Consumer Discretionary
- FENC Health Care
- Exchange
- COOK Nasdaq
- FENC Nasdaq
- Market Cap
- COOK 255.1M
- FENC 222.9M
- IPO Year
- COOK 2021
- FENC 2001
- Fundamental
- Price
- COOK $1.70
- FENC $8.34
- Analyst Decision
- COOK Buy
- FENC Strong Buy
- Analyst Count
- COOK 7
- FENC 2
- Target Price
- COOK $2.43
- FENC $13.00
- AVG Volume (30 Days)
- COOK 791.8K
- FENC 83.2K
- Earning Date
- COOK 08-05-2025
- FENC 08-12-2025
- Dividend Yield
- COOK N/A
- FENC N/A
- EPS Growth
- COOK N/A
- FENC N/A
- EPS
- COOK N/A
- FENC N/A
- Revenue
- COOK $602,441,000.00
- FENC $30,912,000.00
- Revenue This Year
- COOK $0.06
- FENC $0.85
- Revenue Next Year
- COOK $3.18
- FENC $55.16
- P/E Ratio
- COOK N/A
- FENC N/A
- Revenue Growth
- COOK 0.80
- FENC N/A
- 52 Week Low
- COOK $1.28
- FENC $3.96
- 52 Week High
- COOK $3.97
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- COOK 49.85
- FENC 58.31
- Support Level
- COOK $1.72
- FENC $7.53
- Resistance Level
- COOK $1.88
- FENC $8.68
- Average True Range (ATR)
- COOK 0.13
- FENC 0.49
- MACD
- COOK -0.02
- FENC -0.04
- Stochastic Oscillator
- COOK 0.00
- FENC 63.18
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.